2025-04-17 Weibo Corporation HaiPress
BEIJING,April 15,2025 -- Weibo Corporation (the "Weibo" or "Company") (Nasdaq: WB and HKEX: 9898),a leading social media platform in China,today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31,2024 with the U.S. Securities and Exchange Commission on April 15,2025. The annual report can be accessed onWeibo's investor relations website at http://ir.weibo.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements,free of charge,to its shareholders and ADS holders upon request. Requests should be directed to Investor Relations,Weibo Corporation,No.8 SINA Plaza,Courtyard 10,XiBeiWang,Haidian District,Beijing100193,China.
About Weibo
Weibo is a leading social media for people to create,share and discover content online. Weibo combines the means of public self-expression in real time with a powerful platform for social interaction,content aggregation and content distribution. Any user can create and post a feed and attach multi-media and long-form content. User relationships on Weibo may be asymmetric; any user can follow any other user and add comments to a feed while reposting. This simple,asymmetric and distributed nature of Weibo allows an original feed to become a live viral conversation stream.
Weibo enables its advertising and marketing customers to promote their brands,products and services to users. Weibo offers a wide range of advertising and marketing solutions to companies of all sizes. Weibo generates a substantial majority of its revenues from the sale of advertising and marketing services,including the sale of social display advertisement and promoted marketing offerings. Weibo displays content in a simple information feed format and offers native advertisement that conform to the information feed on our platform. We are continuously refining our social interest graph recommendation engine,which enables our customers to perform people marketing and target audiences based on user demographics,social relationships,interests and behaviors,to achieve greater relevance,engagement and marketing effectiveness.
Contacts
Investors Relations
Weibo Corporation
Tel: +86-10-5898-3336
Email:ir@staff.weibo.com
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map